ArticleCancer cell international2021

Correction to: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma.

Xiaobin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.